HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo.

AbstractINTRODUCTION:
A series of molecules designed to be allosteric effectors of hemoglobin were examined for their potential as radiation sensitizers in vitro and in vivo and for their potential as chemosensitizers in vivo as well as for their antimetastatic effect.
RESULTS:
At a concentration of 100 microM for 1 h prior to, during and for 1.5 h after radiation exposure, the allosteric effectors decreased the shoulder of the radiation survival curve of normally oxygenated EMT-6 cells and increased the slope of the radiation survival curves of hypoxic EMT-6 cells resulting in dose-modifying factors of 1.8 to 2.1. In vivo the allosteric effectors had antitumor activity against the Lewis lung carcinoma and produced primarily additive tumor growth delay when administered along with fractionated radiation therapy. When administered on days 4 through 18 after tumor implantation, the allosteric effectors, especially JP-7, RSR-13 and RSR-4, were highly effective antimetastatic agents in animals bearing Lewis lung carcinoma. In cell culture, simultaneous exposure to the allosteric effectors (at 100 microM) effectively sensitized EMT-6 cells to the effects of 4-hydroperoxycyclophosphamide, thiotepa and carboplatin. The allosteric effectors were not very cytotoxic toward EMT-6 tumor cells from tumors treated in vivo with single doses of each molecule nor were these agents very cytotoxic toward bone marrow CFU-GM taken from the same animals.
CONCLUSIONS:
It is likely that the allosteric effectors have a molecular target in addition to hemoglobin. Other possible targets include hydroxymethyl-glutaryl-CoA reductase or microsomal cytochrome b5.
AuthorsB A Teicher, J S Wong, H Takeuchi, L M Gravelin, G Ara, D Buxton
JournalCancer chemotherapy and pharmacology (Cancer Chemother Pharmacol) Vol. 42 Issue 1 Pg. 24-30 ( 1998) ISSN: 0344-5704 [Print] Germany
PMID9619754 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aniline Compounds
  • Antisickling Agents
  • Hemoglobins
  • Propionates
  • Radiation-Sensitizing Agents
  • efaproxiral
Topics
  • Allosteric Regulation
  • Aniline Compounds (pharmacology)
  • Animals
  • Antisickling Agents (pharmacology)
  • Bone Marrow Cells (drug effects)
  • Carcinoma, Lewis Lung (drug therapy, radiotherapy)
  • Colony-Forming Units Assay
  • Combined Modality Therapy
  • Female
  • Hemoglobins (metabolism)
  • Male
  • Mammary Neoplasms, Experimental (drug therapy, radiotherapy)
  • Mice
  • Mice, Inbred C57BL
  • Neoplasm Transplantation
  • Propionates (pharmacology)
  • Radiation-Sensitizing Agents (pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: